TrialThe Lancet. Oncology2011

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.

Richard A Adams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.